3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia
5
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Hodgkin Disease
4
Anemia, Refractory, with Excess of Blasts
4
Myeloproliferative Disorders
3
Multiple Myeloma
3
Graft vs Host Disease
3
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Congenital Abnormalities
2
Burkitt Lymphoma
2
Blast Crisis
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Mycosis Fungoides
1
Interventions
Biopsy
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
Carboplatin
3
larotrectinib
2
erdafitinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Etoposide
2
Cyclophosphamide
2
Cisplatin
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
ivosidenib
1
irinotecan sucrosofate
1
entrectinib
1
elacestrant
1
budigalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Busulfan
×
30 days
×
Clear all
No trials found.